Literature DB >> 21512642

Mesenchymal Stem Cells - Sources and Clinical Applications.

Hans Klingemann1, David Matzilevich, James Marchand.   

Abstract

SUMMARY: Although mesenchymal stem cells (MSC) from different tissue sources share many characteristics and generally fulfill accepted criteria for MSC (plastic adherence, certain surface marker expression, and ability to differentiate into mesenchymal tissues), we are increasingly learning that they can be distinguished at the level of cytokine production and gene expression profiles. Their ability to differentiate into different tissues including endodermal and ectodermal lineages, also varies according to tissue origin. Importantly, MSC from fetal sources can undergo more cell divisions before they reach senescence than MSC from adult tissue such as bone marrow or adipose tissue. As we learn more about the differentiation and plasticity of MSC from different sources, health care providers in the future will use them tailored to different medical indications.

Entities:  

Year:  2008        PMID: 21512642      PMCID: PMC3076359          DOI: 10.1159/000142333

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  37 in total

1.  Stem cell properties of human dental pulp stem cells.

Authors:  S Gronthos; J Brahim; W Li; L W Fisher; N Cherman; A Boyde; P DenBesten; P Gehron Robey; S Shi
Journal:  J Dent Res       Date:  2002-08       Impact factor: 6.116

Review 2.  Mesenchymal stem cells: paradoxes of passaging.

Authors:  Elisabeth H Javazon; Kirstin J Beggs; Alan W Flake
Journal:  Exp Hematol       Date:  2004-05       Impact factor: 3.084

3.  Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.

Authors:  Susanne Kern; Hermann Eichler; Johannes Stoeve; Harald Klüter; Karen Bieback
Journal:  Stem Cells       Date:  2006-01-12       Impact factor: 6.277

4.  Odontogenic capability: bone marrow stromal stem cells versus dental pulp stem cells.

Authors:  Jinhua Yu; Yijing Wang; Zhihong Deng; Liang Tang; Yuanfei Li; Junnan Shi; Yan Jin
Journal:  Biol Cell       Date:  2007-08       Impact factor: 4.458

5.  Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease.

Authors:  Mark L Weiss; Satish Medicetty; Amber R Bledsoe; Raja Shekar Rachakatla; Michael Choi; Shosh Merchav; Yongquan Luo; Mahendra S Rao; Gopalrao Velagaleti; Deryl Troyer
Journal:  Stem Cells       Date:  2005-10-13       Impact factor: 6.277

Review 6.  Wharton's jelly-derived cells are a primitive stromal cell population.

Authors:  Deryl L Troyer; Mark L Weiss
Journal:  Stem Cells       Date:  2007-12-06       Impact factor: 6.277

7.  Comparative analysis of mesenchymal stromal cells from murine bone marrow and amniotic fluid.

Authors:  S Nadri; M Soleimani
Journal:  Cytotherapy       Date:  2007-10-05       Impact factor: 5.414

8.  Comparison of mesenchymal stem cells from different tissues to suppress T-cell activation.

Authors:  Kirsten A Keyser; Karen E Beagles; Hans-Peter Kiem
Journal:  Cell Transplant       Date:  2007       Impact factor: 4.064

9.  Multipotent stem cells from umbilical cord: cord is richer than blood!

Authors:  Mariane Secco; Eder Zucconi; Natassia M Vieira; Luciana L Q Fogaça; Antonia Cerqueira; Maria Denise F Carvalho; Tatiana Jazedje; Oswaldo K Okamoto; Alysson R Muotri; Mayana Zatz
Journal:  Stem Cells       Date:  2007-10-11       Impact factor: 6.277

Review 10.  Stem cell therapy for autism.

Authors:  Thomas E Ichim; Fabio Solano; Eduardo Glenn; Frank Morales; Leonard Smith; George Zabrecky; Neil H Riordan
Journal:  J Transl Med       Date:  2007-06-27       Impact factor: 5.531

View more
  52 in total

Review 1.  Mesenchymal stem cells in the pathogenesis and therapy of breast cancer.

Authors:  Christelle P El-Haibi; Antoine E Karnoub
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-12-21       Impact factor: 2.673

2.  Human mesenchymal stem cells derived from limb bud can differentiate into all three embryonic germ layers lineages.

Authors:  Fei Jiao; Juan Wang; Zhao-Lun Dong; Min-Juan Wu; Ting-Bao Zhao; Dan-Dan Li; Xin Wang
Journal:  Cell Reprogram       Date:  2012-07-09       Impact factor: 1.987

Review 3.  Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures.

Authors:  Karen Bieback
Journal:  Transfus Med Hemother       Date:  2013-08-26       Impact factor: 3.747

4.  Expression of Desmoglein 2, Desmocollin 3 and Plakophilin 2 in Placenta and Bone Marrow-Derived Mesenchymal Stromal Cells.

Authors:  Melanie L Hart; Elisa Rusch; Marvin Kaupp; Kay Nieselt; Wilhelm K Aicher
Journal:  Stem Cell Rev Rep       Date:  2017-04       Impact factor: 5.739

5.  Clinical grade adult stem cell banking.

Authors:  Sreedhar Thirumala; W Scott Goebel; Erik J Woods
Journal:  Organogenesis       Date:  2009-07       Impact factor: 2.500

6.  MSC - a Multipotent Stromal Cell in Search of Clinical Application.

Authors:  Torsten Tonn; Dagmar Barz
Journal:  Transfus Med Hemother       Date:  2008-07-21       Impact factor: 3.747

7.  Cardiopoietic stem cell therapy restores infarction-altered cardiac proteome.

Authors:  D Kent Arrell; Christian S Rosenow; Satsuki Yamada; Atta Behfar; Andre Terzic
Journal:  NPJ Regen Med       Date:  2020-03-12

8.  Bone marrow-derived mesenchymal stem cells reduce immune reaction in a mouse model of allergic rhinitis.

Authors:  Ning Zhao; Yanjuan Liu; Hongfeng Liang; Xuejun Jiang
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

Review 9.  Therapeutic potential of mesenchymal stem cells in treating both types of diabetes mellitus and associated diseases.

Authors:  Vidul Goenka; Tanhai Borkar; Aska Desai; Raunak Kumar Das
Journal:  J Diabetes Metab Disord       Date:  2020-10-17

10.  Mesenchymal stem cells as an appropriate feeder layer for prolonged in vitro culture of human induced pluripotent stem cells.

Authors:  Parvaneh Havasi; Mohammad Nabioni; Masoud Soleimani; Behnaz Bakhshandeh; Kazem Parivar
Journal:  Mol Biol Rep       Date:  2013-01-03       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.